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mental event, the physiologic understanding of the
Fontan circulation has been evolving steadily, with var-
ious modifications and expanding applications in
patients with univentricular heart disease. Patients who
have undergone these or further modifications of the
Fontan procedure may have progressive exercise intol-
erance, atrial arrhythmias, recurrent effusions, and pro-
tein-losing enteropathy, as well as other manifestations
of chronic congestive failure and a malfunctioning atrio-
pulmonary connection.2-4 The increase in right atrial
size and pressure that occurs in the setting of an atrio-
pulmonary Fontan connection has been hypothesized to
cause turbulence and energy loss, compression of the
pulmonary veins, coronary sinus hypertension, arrhyth-
mias, and atrial thrombus.5-7
Few therapeutic options are available for patients hav-
ing these problems. Management is for the most part
I n 1971, Professor Fontan first constructed a com-pletely in-series circulation with exclusion of the right
ventricle, using the right atrium as a dynamic element,
in a patient with tricuspid atresia.1 Since this monu-
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limited to orthotopic heart transplantation or revision of
the Fontan connection. Revision to a lateral tunnel has
been described by several investigators,7-9 and in recent
years a number of centers have adopted conversion to
an extracardiac conduit total cavopulmonary anastomo-
sis as the therapy of choice for patients with Fontan
failure.10-12 The aim of the current study is to present a
multicenter experience with conversion of previous
Fontan connections to total extracardiac cavopul-
monary anastomosis, including patients undergoing
revision at the Hesperia Hospital in Modena (Italy), the
University of California at San Francisco (California),
the Children’s Memorial Hospital in Chicago (Illinois),
and the Clinique St Augustin in Bordeaux (France).
Patients and methods
Patients. Between October 1992 and January 1999, 31
patients between 6 and 36 years of age (mean ± SD 19.9 ± 8.8
years) underwent conversion of an atriopulmonary (n = 29),
atrioventricular (n = 1), or lateral tunnel (n = 1) Fontan con-
nection to total extracardiac cavopulmonary anastomosis at
the four institutions listed above. Some of these patients have
been included in previous reports.10-12 The interval between
the original Fontan procedure and conversion to an extracar-
diac cavopulmonary anastomosis ranged from 6 to 20.5 years
(mean ± SD 12.1 ± 4.8 years). Three patients had undergone
a revision of the Fontan procedure (replacement of the valved
conduit with a nonvalved synthetic tube) from 8.1 to 12 years
after the original procedure and from 6 to 10 years before the
conversion. All patients had undergone palliative shunting
procedures or classic superior cavopulmonary anastomosis
before the initial Fontan operation. Primary diagnoses were
univentricular transposition complexes (n = 10), tricuspid
atresia with or without pulmonary stenosis/atresia (n = 11),
double-inlet left ventricle (n = 5), double-outlet right ventri-
cle and mitral atresia (n = 2), pulmonary atresia and intact
ventricular septum (n = 2), and unbalanced complete atrio-
ventricular septal defect (n = 1). Echocardiography and car-
diac catheterization were performed before revision in all
patients.
Patients had a wide range of complications of the original
Fontan connection. All patients were clinically symptomatic,
with 13 patients in New York Heart Association (NYHA)
class IV, 12 in class III, and 6 in class II. Ventricular function
measured by echocardiography was considered good or only
mildly decreased in 20 patients and poor in 11 patients. At
preoperative catheterization, the ventricular end-diastolic
pressure ranged from 2 to 13 mm Hg (mean ± SD 7.4 ± 3.6
mm Hg). Atrial arrhythmias were present in almost all
patients, although these were not hemodynamically or clini-
cally significant in all cases: 10 patients had supraventricular
tachycardia causing hemodynamic compromise or syncopal
episodes, necessitating repeated hospitalizations and multiple
antiarrhythmic medications; 9 patients had atrial flutter; 1 had
atrial fibrillation; 3 had first-degree atrioventricular block;
and 5 had previously undergone implantation of a permanent
bipolar epicardial pacemaker because of atrioventricular
block (n = 4) or sick sinus syndrome (n = 1). Three patients
did not have documented rhythm disturbances. Pleural and
pericardial effusions were present in 10 patients, and 3
patients had ascites and protein-losing enteropathy necessi-
tating long-term albumin supplementation. The cardiac index
was less than 2 L · min–1 · m–2 in 10 patients. Compression of
the pulmonary veins by the enlarged right atrium was docu-
mented by 2-dimensional echocardiography in 6 patients.
The mean right atrial pressure was 15.2 mm Hg and was 20
mm Hg or more in 5 patients, 2 of whom had a large throm-
bus filling the right atrium. Pulmonary artery pressure aver-
aged 13.2 ± 5.2 mm Hg. Obstruction of the Fontan pathway
(pressure gradient ≥ 3 mm Hg between the superior vena cava
and pulmonary artery) was present in 14 patients. Significant
atrioventricular valve regurgitation was present in 8 patients,
with moderate or severe regurgitation in 3 and mild regurgi-
tation in 5. The mean ± SD systemic oxyhemoglobin satura-
tion was 88% ± 5%. Nine patients had arterial oxygen satu-
rations less than 90%, 5 of whom had a baffle leak or partial
patch detachment. None had fenestrations before revision.
Four patients had ventilation/perfusion ratio mismatch
because of pulmonary arteriovenous malformations.
Operative techniques. Careful redo median sternotomy
was the surgical approach. Standard techniques of cardiopul-
monary bypass were used, with aortic and bicaval cannula-
tion and moderate hypothermia (28°C-32°C). Seven patients
were placed on cardiopulmonary bypass by means of femoro-
femoral cannulation and then transitioned to aortic and bicav-
al cannulation after successful sternotomy and exposure of
the heart and great vessels. After institution of bypass, the
aorta was crossclamped and cold crystalloid or blood cardio-
plegic solution was given into the aortic root. The technique
of cardiopulmonary bypass was modified as necessary
according to the additional anomalies. In 6 patients, deep
hypothermic circulatory arrest was used.
Conversion to a total extracardiac cavopulmonary connec-
tion was carried out with a conduit from the inferior vena
cava to the right pulmonary artery. A nonvalved polytetraflu-
oroethylene tube graft was used in 25 patients, an allograft
conduit in 3, and a Dacron tube in 3. The diameter of the con-
duit was matched to that of the inferior vena cava and ranged
from 20 to 25 mm. In patients without a previously placed
bidirectional superior cavopulmonary connection, either this
procedure was performed or a prior classic Glenn shunt was
incorporated into the extracardiac Fontan circuit. In 1 patient,
an aortic allograft was used to restore pulmonary arterial con-
tinuity. In 21 patients (68%), reduction right atrioplasty was
performed on the anterior right atrial wall, away from the
conduction tissue; the crista terminalis was not resected.
Reconstruction or augmentation (or both) of the pulmonary
arteries was carried out in 11 patients. In 6 patients, intraop-
erative mapping and cryoablation of arrhythmia circuits was
performed and an antitachycardia pacemaker was placed. In
2 other patients, both of whom underwent reduction right
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atrioplasty, a modified maze procedure was performed. Two
patients required right atrial thrombectomy and 2 underwent
ligation of a left superior vena cava. In 1 patient, a severely
regurgitant tricuspid valve was closed with a patch. In the
other patients with atrioventricular valve regurgitation before
revision, no procedures were performed on the valve. In 1
patient, the bulboventricular foramen was enlarged through
the right atrium and aortic valve by resecting a wedge of tis-
sue from the apical trabecular septum, which was incised
close to the obtuse margin of the ventricular mass. No other
intracardiac procedures were performed and no atrial/conduit
fenestrations were used.
Results
Operative and early postoperative results. There
were 2 operative deaths. A 25 year-old patient died of
irreversible congestive heart failure shortly after the
operation. Preoperatively, the patient had effusions,
compression of the right pulmonary veins, moderate to
severe mitral regurgitation, and was in NYHA func-
tional class IV. This patient tolerated the procedure
well and was in stable condition with the support of
inotropic drugs. However, after sternal closure the
patient had a cardiac arrest and did not respond to
resuscitative efforts. The second perioperative death
occurred in a patient with severe cachexia and multiple
complications of the Fontan circulation, in whom trans-
plantation was contraindicated for social reasons. This
patient (who had severe effusions, protein-losing
enteropathy, and congestive heart failure before the
operation) experienced massive effusions with increas-
ing acidosis. On the fourth postoperative day, he was
returned to the operating room, where in a salvage
attempt the Fontan connection was taken down to a
bidirectional cavopulmonary anastomosis with a sup-
plemental modified Blalock-Taussig shunt. The hemo-
dynamic status continued to decline, and shortly after
reoperation the patient had a cardiac arrest and could
not be resuscitated.
Five other patients underwent early reoperation: 1
patient required reoperation for cardiac tamponade due
to chronic pericardial effusion, and 4 had permanent
dual-chamber epicardial pacemakers placed. The
remaining patients required postoperative mechanical
ventilation for a median of 13 hours (7-29 hours) and
inotropic medications for a median of 3 days (1-5
days). Effusions resolved within 30 days in all surviv-
ing patients in whom they were present before revision,
but 1 patient had significant new effusions develop,
necessitating chest tube drainage for 21 days. The con-
dition of 2 patients with protein-losing enteropathy
improved, and within 30 days their serum albumin lev-
els increased without exogenous replacement to 3.5
and 4.5 g/dL from 2 and 2.3 g/dL, respectively. In addi-
tion to the patients who had placement of a permanent
epicardial pacemaker, 6 patients had persistence of pre-
revision arrhythmias, which were controlled effective-
ly with medical therapy. One patient who did not have
preoperative rhythm disturbances had atrial flutter/fib-
rillation develop after the operation. In 15 patients, pre-
revision arrhythmias were improved. In 9 of these
patients, the arrhythmias disappeared, and in 6 they
became responsive to medical therapy whereas they
were unresponsive before the operation. All but 1 of
these patients had undergone reduction right atrioplas-
ty. Arrhythmias were controlled in all of the patients
who underwent intraoperative cryoablation except for
1, who had recurrent supraventricular tachycardia that
was controlled with procainamide. Of the 29 early sur-
vivors, 24 were discharged receiving warfarin sodium
therapy (international normalized ratio maintained in
the 1.5 to 2.0 range), and the remaining 5 were placed
on an aspirin regimen.
Follow-up. Cross-sectional follow-up was obtained
in all hospital survivors, with a median duration of 25
months (4-61 months). One death occurred during the
follow-up period in a patient who died 8 months after
the operation of a malignant arrhythmia. Preopera-
tively, this patient had a permanent pacemaker because
of atrioventricular block, and in the early postoperative
period this patient did not manifest any new arrhythmia
activity. No autopsy was performed. One patient had
recurrent, refractory atrial flutter and progressive ven-
tricular dysfunction, necessitating placement of a pace-
maker 8 months after the operation and orthotopic
heart transplantation 18 months after revision. At fol-
low-up 10 months later, the patient is alive and in sta-
ble condition in NYHA class I. One patient required
late reoperation for wound infection 2 months after
revision.
At most recent follow-up, all surviving patients were
in NYHA functional class I (n = 20) or II (n = 7) except
for the patient who required heart transplantation. This
patient was initially in NYHA class II after revision,
deteriorated to class IV, and after transplantation was in
NYHA class I. All patients had follow-up echocardiog-
raphy, which demonstrated improvement in atrioven-
tricular valve regurgitation in both patients with mod-
erate to severe regurgitation who did not undergo
procedures on the atrioventricular valve at the time of
reintervention. New atrioventricular or semilunar valve
regurgitation had not developed in any patient. No
patients had evidence of a decline in ventricular func-
tion except for the patient who underwent heart trans-
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plantation. In the remaining patients, ventricular func-
tion was normal or unchanged after revision, with sig-
nificantly improved systolic and diastolic function in 4
patients. Follow-up catheterization was performed in 6
patients.
Discussion
Few therapeutic options are available for patients
with a Fontan connection and deteriorating functional
status. Conservative medical therapy may be sufficient
if the patient is in reasonably functional condition.
Several investigators have reported orthotopic heart
transplantation as management options for patients
with end-stage disease.8-12 However, there is a group of
patients with deteriorating functional status in whom a
better first option may be conversion of the failing
Fontan circuit to total cavopulmonary connection.
Specific indications for an optimal timing of this
approach are not clearly defined. The most obvious
candidates for conversion are patients with complica-
tions that stand to be addressed directly by revision,
including a giant atrium with thrombus, arrhythmias
refractory to medical or simple electrophysiologic
treatment, pulmonary venous obstruction by the
enlarged right atrium, and ventricular dysfunction
resulting from elevated coronary sinus pressure.9,11,12
Patients with intrinsic myocardial dysfunction are less
likely to benefit from conversion, although select
patients in this category may benefit. It can be difficult
to determine the extent to which the ventricular dys-
function is related to arrhythmias and/or coronary sinus
hypertension, which may be in part reversible.
Among the several modifications of the Fontan pro-
cedure to which a failing connection may be converted,
we believe that total cavopulmonary anastomosis with
an extracardiac conduit is a good option in most
instances. Although several investigators have reported
improvement after conversion to an intracardiac lateral
tunnel type connection,7-9 an extracardiac total
cavopulmonary anastomosis may be preferable in the
long run because of several potential advantages. Not
only is an extracardiac Fontan operation easier and
more flexible to perform, especially in patients with
extensive prior surgery, but it can be expected to result
in superior hydrodynamic efficiency13 and allows more
aggressive strategies to minimize residual or recurrent
complications related to the right atrium. The extracar-
diac conduit approach avoids additional atrial suture
lines (except for that required to close the reduction
atrioplasty) and allows more extensive reduction right
atrioplasty, which not only eliminates the dysfunction
and arrhythmogenic right atrial tissue in the Fontan
pathway, but provides a convenient bed for placement
of the conduit. There are numerous other potential ben-
efits of extracardiac total cavopulmonary anastomosis,
which have been detailed elsewhere and will not be
elaborated on in this discussion.14,15
In this multicenter experience with 31 patients, the
two principal indications for conversion were arrhyth-
mias and hydrodynamic inefficiency of the Fontan cir-
cuit, with atrial tachyarrhythmias in 20 patients and
progressive congestive heart failure in 17. Although
patients with specific complications of the previous
Fontan procedure are most likely to benefit from revi-
sion, the utility of conversion in patients with deterio-
rating functional status and no specific target condi-
tions is questionable. This would include patients with
significantly depressed ventricular function, as well as
patients with very limited functional status who have
moderately elevated pulmonary vascular resistance,
moderately depressed ventricular function, a large right
atrium without specific complications, and no obstruc-
tive lesion. This group of highly debilitated patients
may not tolerate the insult of the operation itself.
However, they may not tolerate transplantation either,
and the relative risks and benefits of the two approach-
es should be assessed. It should be kept in mind, how-
ever, that ventricular function may be improved in
patients with less significant impairment simply by
decreasing the pressure in the right atrium and coro-
nary sinus, which is illustrated by the fact that many of
our patients had a reduction in ventricular end-diastolic
pressure after revision.
All of the patients who survived the perioperative
period had an immediate clinical improvement after
conversion. The only perioperative deaths were in
especially ill patients, who were suboptimal candidates
for revision but in whom this was the only realistic
option. In general, the particular complications (such as
obstruction of the Fontan pathway or pulmonary veins,
arrhythmias, and effusions) were rectified, presumably
restoring some degree of integrity to the Fontan circuit.
In many patients, at least part of the improvement could
be traced to effective control of previously intractable
arrhythmias. Although 4 patients had a new pacemaker
placed at the time of revision (not including the 6 in
whom intraoperative cryoablation and placement of an
antitachycardia pacemaker was performed), arrhyth-
mias were improved substantially in 15 patients. Six
patients were treated intraoperatively with cryoabla-
tion, 2 had a modified maze procedure, and most
underwent reduction right atrioplasty, which should be
considered almost an essential component of conver-
sion of a failing Fontan connection to extracardiac con-
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duit cavopulmonary anastomosis. This applies to
patients without as well as with preoperative arrhyth-
mias. Chronic right atrial hypertension and resulting
distention alters the electrical characteristics of the atri-
al myocardium, increasing its susceptibility to arrhyth-
mogenesis. Even if the tachyarrhythmias characteristic
of a failing Fontan shunt have yet to manifest them-
selves in a given patient, the threshold for such arrhyth-
mias in the perioperative period is likely to be lowered,
and reduction right atrioplasty is likely to be beneficial.
Moreover, these patients may have some degree of
obstruction of the right pulmonary veins because of
compression by the dilated right atrium. This compli-
cation was diagnosed in 20% of the patients in this
series and was likely present to a less obvious extent in
others as well. Resection of dilated right atrial free wall
may help to eliminate this and other potential mass
effects and provides additional space in the medi-
astinum for placement of the conduit. Although none of
the patients in this series had fenestration of the extra-
cardiac cavopulmonary connection, fenestration may
help reduce the duration of effusions in some patients.
However, post-conversion effusions were not a com-
mon complication in the present series, and we do not
have sufficient data to recommend or not recommend
fenestration in this group of patients.
A frequent and vexing complication of the modified
Fontan procedure is protein-losing enteropathy. The
causes of this complication are not well understood,
nor are the factors that may contribute to effective ther-
apy. Two of 3 patients with this complication in the pres-
ent cohort improved within 30 days, presumably
because of altered hemodynamic conditions. The num-
ber of patients with protein-losing enteropathy in this
series is too few to recommend revision specifically for
this complication, but substantial improvement in 2 of
3 patients suggests that it may be a worthwhile option
in appropriate patients. Further investigation is war-
ranted to determine which patients with this complica-
tion may benefit from conversion to total extracardiac
cavopulmonary connection. 
In conclusion, revision of the failing Fontan to extra-
cardiac conduit total cavopulmonary connection can be
performed with significant improvement in most
patients and low mortality (10%) and morbidity. Opti-
mal selection criteria for conversion have yet to be
determined, but most patients can be expected to bene-
fit to some extent. The degree of improvement is likely
to correspond with the proportion of complications of
the previous Fontan connection in a given patient that
can be addressed by conversion. The significance of
these cumulative results is profound, considering that
the only alternative for many of these patients is car-
diac transplantation.
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Discussion
Dr John E. Mayer (Boston, Mass). The management of
patients with a failing Fontan circulation may become an
increasingly important problem for us over the next several
years. We now have an ever-increasing cohort of patients who
have survived a Fontan-type operation, and yet the natural
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history of the patient with a Fontan circulation is still being
written. I certainly congratulate you on bringing this com-
bined experience from four institutions to us and bringing this
topic onto the agenda for us to consider. I have a few points
that I thought would be important to address.
One is the issue of postoperative arrhythmias. What role do
you currently think the maze procedures or modified maze
procedures or other antiarrhythmic types of operations would
have in future management of similar kinds of patients? 
My second question probably reflects the local custom in
our institution regarding fenestration: Do you think there is
any significant role for fenestration as part of a conversion
from a so-called classic Fontan operation to a more recent
version?
The third area in which I have a question, and I think it is
always hard to determine this when you have patients who
have multiple indications for an operation, is that of protein-
losing enteropathy. We have certainly observed patients who
had relatively favorable hemodynamics in terms of right atri-
al pressures and still had protein-losing enteropathy. We have
wondered again recently about the role of lymphatic dys-
function in the origin of this kind of problem. Do you think
this protein-losing enteropathy is simply attributable to the
hemodynamics of the Fontan circulation or might other fac-
tors be contributing?
Dr Marcelletti. Thank you very much. I will answer ques-
tions two and three, and I will ask Constantine Mavroudis to
give his contribution on the arrhythmia issue, since he has
been the most active in this field.
We do not have any strong feeling against fenestration. If
coming off cardiopulmonary bypass is somewhat difficult,
fenestration will be considered. It is of interest that we did not
find any need to fenestrate in this group of patients. 
With regard to protein-losing enteropathy, we do not have
much experimental data, but we have some clinical data. We
have reported separately in The Annals of Thoracic Surgery
the results of 3 patients who completely healed after conver-
sion. We believe that protein-losing enteropathy has much to
do with the energy loss and the turbulence in the right atrium,
which slows the flow even when the mean right atrial and pul-
monary artery pressures remain in the range of 15 to 18 mm
Hg. Protein-losing enteropathy may be treated by conversion
to an extracardiac Fontan, simply because the flows in the
inferior vena cava, right atrium, and pulmonary artery
improve, becoming more laminar.
Dr Constantine Mavroudis (Chicago, Ill). I would like to
congratulate Dr Marcelletti for a remarkable synthesis of data
from different institutions. Dr Mayer, your comments are
very well taken. Our profession is following a large group of
atriopulmonary Fontan patients who are getting older and
who are now having significant atrial arrhythmias, among
other conditions. Recent modifications of the Fontan opera-
tion incorporating lateral tunnel and extracardiac techniques
may limit the incidence of atrial tachycardia, as shown in pre-
liminary studies by Dr Laks and others. I suspect, however,
that it is only a matter of time before troubling tachycardias
affect these patients as well.
The potential for future atrial arrhythmias, anatomic
obstructions, and other structural problems in these patients is
high. Initial reports by Drs Laks, Kreutzer, McElhinney, and
Vitullo extolled the virtues of the “redo atriopulmonary to
total cavopulmonary artery conversion without arrhythmia”
operation to treat the troubling anatomic and electrophysio-
logic problems that some of these patients face.
Unfortunately, their results did not show consistent ablation
of atrial arrhythmias. Our approach is to identify Fontan
patients with troubling arrhythmias and/or anatomic abnor-
malities and consider an “extracardiac total cavopulmonary
artery Fontan conversion with arrhythmia” operation, con-
sisting of a modified right-sided maze procedure or a Cox
maze III procedure in the event that the patient has atrial fib-
rillation. An atrial pacemaker is also inserted to maintain atrio-
ventricular conduction. We have now operated on 22 patients
who had Fontan conversion and arrhythmia surgery without
short- or long-term mortality. Late postoperative arrhythmias
occurred in two patients who are receiving long-term antiar-
rhythmic medications. All patients, except one who is on the
transplant list for persistent left ventricular failure, are in
NYHA class I or II. We believe that total cavopulmonary
artery Fontan conversion in association with modified right-
sided maze or Cox maze III procedures and pacemaker place-
ment can be accomplished with low morbidity and mortality
and results in functional class improvement and control of
life-threatening arrhythmias.
Dr Antonio Amodeo (Rome, Italy). I have two questions. 
You have been using, presumably, an aortic homograft for
the extracardiac tunnel. We have done more than 120 extra-
cardiac conduits, and we have used the aortic homograft as a
lateral tunnel in three. One of these three homografts needed
to be replaced. Another one is going to be replaced because
of heavy calcification of the aortic wall causing a stenosis
proximal to the pulmonary arteries. This kind of stenosis can-
not be treated by balloon dilatation because of the heavy cal-
cification of the homograft, whereas we currently use balloon
dilatation for the polytetrafluoroethylene tube. Do you have
any similar experiences when using aortic homografts? We
no longer use aortic homografts to construct an extracardiac
tunnel. 
Second, you used a reconversion for one or two patients in
NYHA class I. Do you think that all of the old aortopul-
monary connections should be reconverted in an extracardiac
tunnel? What are the early criteria to reconvert this old aor-
topulmonary connection? 
Dr Marcelletti. With regard to the homograft, we are
aware that some have calcified in the setting of an extracar-
diac Fontan conduit. The choice of the optimal conduit is still
uncertain. In the opinion of most surgeons with experience in
such operations, the polytetrafluoroethylene tube is a reliable
conduit. 
The indication to convert to extracardiac Fontan is based
mostly on the enlargement of the right atrium, the so-called
giant right atrium. It might not be giant, but it might already
be enlarging. Such enlargement will shortly be accompanied
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by symptoms such as arrhythmias, exercise intolerance, and
protein-losing enteropathy. I think the basic alarm for taking
down the previous Fontan conduit is the size of the right
atrium.
Dr Joseph J. Amato (Chicago, Ill). Perhaps I am missing
a point. I noted that you only had one lateral tunnel failure.
I do not think you told us the reason for that lateral tunnel
failing. 
Like many of us who do lateral tunnels, I am concerned
that in the growing child, if an extracardiac conduit is used,
there is no other alternative but to replace the conduit as the
child grows. Why not convert these from giant atria to lateral
tunnel formations rather than extracardiac conduits? 
Dr Marcelletti. The problem related to the lateral tunnel
was thrombosis of the tunnel, which required revision to an
extracardiac connection.
With regard to conversion of the previous Fontan, most of
these patients have reached almost adult age, so we believe
that the conduit will not need to be replaced. If the inferior
vena cava remains around 20 to 25 mm, it should be all
right. So far, none of the more than 200 patients with an
extracardiac Fontan connection has required conduit
replacement. 
Dr Hillel Laks (Los Angeles, Calif). I have two questions:
First, what was the arterial oxygen saturation of these patients
before and after the operation? Second, what type of antico-
agulation are you recommending over the short and long term
for the extracardiac conduit? 
I have one comment with regard to the fenestration. As
opposed to the usual first Fontan procedure, during which the
patients are cyanotic, these patients have saturations that are
usually 92% to 94%. I would be interested to hear what your
patients’ saturations were. 
We have found that in the revision we have made connec-
tions between the extracardiac conduit and the right atrium,
either a direct window or a short polytetrafluoroethylene
graft, and have found that these patients tolerate desaturation
far less well than the first-time Fontan procedures. Some of
our patients have become acidotic with saturations getting
down into the 80% range. It is very useful in these patients to
have an adjustable snare around the connection so that if the
saturation is too low, the size of that communication can be
readjusted.
Dr Marcelletti. I agree with you that fenestration might
induce the problem of desaturation. We should not have any
prejudice against fenestration in a patient who is having dif-
ficulty in being weaned from bypass, but I also believe that
we should aim at full oxygen saturation after surgery.
Dr Laks. And the anticoagulation regimen? 
Dr Marcelletti. We have been using warfarin sodium
(Coumadin) for the first year after conversion. In the begin-
ning of our experience, we monitored our patients with mag-
netic resonance imaging to see whether there was significant
neointima deposition inside the conduit. We have observed
only a small reduction in the inside diameter of the conduit.
After 1 year, we convert to aspirin therapy.
Dr Laks. We recently did a transplant on a 17-year-old
patient who had had an extracardiac Fontan revision 2 years
earlier and was maintained on warfarin. There were patches
of pseudointima built up and calcification within the polyte-
trafluoroethylene tube. I was a bit worried about the long-
term outcomes and the question of whether warfarin com-
bined with antiplatelet agents should not be used for a longer
term, but there were patches of calcification within this tube.
Dr Marcelletti. I think that calcification and thrombus
deposition inside the conduit after surgery has much more
to do with the low output state than with the mode of anti-
coagulation. 
